炎症性肠病中贫血的发病率、患病率及临床结局:一项基于人群的队列研究
该研究从瑞典厄勒布鲁大学医院基于人群的炎症性肠病队列(1405例,1963—2010年诊断)中随机抽取342例,提取2011年1月1日至2013年12月31日的血红蛋白检测数据,分析贫血的发病率、患病率及12个月内贫血缓解情况。结果显示克罗恩病贫血发病率和患病率均高于溃疡性结肠炎,且克罗恩病患者12个月内贫血缓解率更低(56% vs 75%,P=0.03)。
要点
- 克罗恩病贫血发病率为19.3/100人年,患病率28.7%,均高于溃疡性结肠炎的12.9/100人年和16.5%。
- 克罗恩病较溃疡性结肠炎贫血发病风险OR=1.60、患病风险OR=2.04。
- 克罗恩病患者12个月内贫血缓解率56%,低于溃疡性结肠炎的75%(P=0.03)。
核心结论
- 贫血是炎症性肠病的常见表现,即使在诊断后多年仍可发生;克罗恩病与更高的贫血风险和更差的结局相关。
研究设计与样本
- 基于人群的队列研究,从瑞典厄勒布鲁大学医院炎症性肠病队列(1405例,1963—2010年诊断)中随机抽取342例,提取2011年1月1日至2013年12月31日的血红蛋白检测数据。
主要发现
- 克罗恩病贫血发病率为19.3(95%CI:15.4-23.7)/100人年,患病率为28.7%(95%CI:22.0-36.2);溃疡性结肠炎分别为12.9(95%CI:9.8-16.5)/100人年和16.5%(95%CI:11.2-22.9)。
- 与溃疡性结肠炎相比,克罗恩病贫血发病风险OR=1.60(95%CI:1.02-2.51),患病风险OR=2.04(95%CI:1.20-3.46)。
- 克罗恩病狭窄型表型与贫血风险升高相关(HR=2.59;95%CI:1.00-6.79),溃疡性结肠炎广泛病变与贫血风险升高相关(HR=2.40;95%CI:1.10-5.36)。
- 克罗恩病患者在贫血诊断后3个月内接受特异性治疗的概率更高,但12个月内贫血缓解率更低(56% vs 75%;P=0.03)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence and short-term outcome of anaemia in inflammatory bowel disease (IBD) are largely unknown. AIM: To determine the incidence, prevalence and clinical outcome of anaemia in terms of resolution of anaemia within 12 months. We also planned to assess risk factors for anaemia in IBD. METHODS: A random sample of 342 patients was obtained from the population-based IBD cohort of Örebro University Hospital, Sweden, consisting of 1405 patients diagnosed between 1963 and 2010. Haemoglobin measurements recorded from 1 January 2011 to 31 December 2013 were extracted from the Clinical Chemistry data system. RESULTS: In Crohn's disease, the incidence rate of anaemia was 19.3 (95% CI: 15.4-23.7) per 100 person-years and the prevalence was 28.7% (CI: 22.0-36.2), compared with 12.9 (CI: 9.8-16.5) and 16.5% (CI: 11.2-22.9) for ulcerative colitis. Crohn's disease was associated with an increased incidence (OR = 1.60; CI: 1.02-2.51) and prevalence of anaemia (OR = 2.04; CI: 1.20-3.46) compared to ulcerative colitis. Stricturing disease phenotype in Crohn's disease (HR = 2.59; CI: 1.00-6.79) and extensive disease in ulcerative colitis (HR = 2.40; CI: 1.10-5.36) were associated with an increased risk of anaemia. Despite a higher probability of receiving specific therapy within 3 months from the diagnosis of anaemia, Crohn's disease patients had a worse outcome in terms of resolution of anaemia within 12 months (56% vs 75%; P = 0.03). CONCLUSIONS: Anaemia is a common manifestation of IBD even beyond the first years after the diagnosis of IBD. Crohn's disease is associated with both an increased risk and a worse outcome.
引用
- Eriksson C, Henriksson I, Brus O, et al. Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population-based cohort study. Aliment Pharmacol Ther. 2018. PMID: 30069892. doi:10.1111/apt.14920
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。